ANGO
ANGO
NASDAQ · Health Care

Angiodynamics Inc

$15.11
-0.01 (-0.07%)
As of Oct 3, 2:07 AM ET ·
Financial Highlights (FY 2026)
Revenue
322.42M
Net Income
-37,000,456
Gross Margin
54.6%
Profit Margin
-11.5%
Rev Growth
-1.9%
D/E Ratio
0.03
Revenue & Net Income
Margin Trends
FY 2026 FY 2025 FY 2024 FY 2023
Gross Margin 54.6% 54.6% 30.9% 30.9%
Operating Margin -12.5% -11.2% 21.0% 18.9%
Profit Margin -11.5% -10.9% 17.3% 13.7%
Income Statement
FY 2026 FY 2025 FY 2024 FY 2023
Revenue 322.42M 328.57M 101.13M 92.93M
Gross Profit 176.11M 179.46M 31.21M 28.68M
Operating Income -40,206,295 -36,875,232 21.24M 17.55M
Net Income -37,000,456 -33,934,994 17.51M 12.74M
Gross Margin 54.6% 54.6% 30.9% 30.9%
Operating Margin -12.5% -11.2% 21.0% 18.9%
Profit Margin -11.5% -10.9% 17.3% 13.7%
Rev Growth -1.9% -1.9% +21.6% +13.5%
Balance Sheet
FY 2026 FY 2025 FY 2024 FY 2023
Total Debt 10.39M 10.39M 20.80M 26.73M
Total Equity 305.55M 305.55M 316.66M 268.59M
D/E Ratio 0.03 0.03 0.07 0.10
Cash Flow
FY 2026 FY 2025 FY 2024 FY 2023
EBITDA -29,452,329 -28,512,903 29.28M 26.49M
Free Cash Flow — — 17.77M 16.03M